{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:55:24Z","timestamp":1793109324755,"version":"4.5.0"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of aging","award":["AG08017"],"award-info":[{"award-number":["AG08017"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0191815","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T13:30:09Z","timestamp":1520429409000},"page":"e0191815","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":72,"title":["Augmented frontal cortex diacylglycerol levels in Parkinson\u2019s disease and Lewy Body Disease"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5853-9936","authenticated-orcid":true,"given":"Paul L.","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Tippireddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Feriante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall L.","family":"Woltjer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/alzrt103","article-title":"Lipidomics of Alzheimer's disease: current status","volume":"4","author":"PL Wood","year":"2012","journal-title":"Alzheimers Res Ther"},{"key":"ref2","first-page":"4","article-title":"Critical assessment of the status of Alzheimer\u2019s disease Biomarkers","volume":"1","author":"PL Wood","year":"2014","journal-title":"J. Parkinson\u2019s disease & Alzheimer\u2019s disease"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1503\/jpn.090059","article-title":"Circulating plasmalogen levels and Alzheimer Disease Assessment Scale-Cognitive scores in Alzheimer patients","volume":"35","author":"PL Wood","year":"2010","journal-title":"J Psychiatry Neurosci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1074\/jbc.M111.274142","article-title":"Comparative lipidomic analysis of mouse and human brain with Alzheimer disease","volume":"287","author":"RB Chan","year":"2012","journal-title":"J Biol Chem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1017\/neu.2015.18","article-title":"Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects","volume":"27","author":"PL Wood","year":"2015","journal-title":"Acta Neuropsychiatr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-150336","article-title":"Targeted Lipidomics of Fontal Cortex and Plasma Diacylglycerols (DAG) in Mild Cognitive Impairment and Alzheimer's Disease: Validation of DAG Accumulation Early in the Pathophysiology of Alzheimer's Disease","volume":"48","author":"PL Wood","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bbacli.2015.11.004","article-title":"Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD)","volume":"5","author":"PL Wood","year":"2015","journal-title":"BBA Clin"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.neurobiolaging.2014.02.025","article-title":"Brain lipidomes of subcortical ischemic vascular dementia and mixed dementia","volume":"35","author":"SM Lam","year":"2014","journal-title":"Neurobiol Aging"},{"key":"ref9","first-page":"1001","article-title":"Increased lysophosphatidylethanolamine and diacylglycerol levels in Alzheimer\u2019s disease plasma","volume":"1","author":"PL Wood","year":"2014","journal-title":"JSM Alzheimer\u2019s Disease and Related Dementia"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.talanta.2014.07.075","article-title":"Application of a novel metabolomic approach based on atmospheric pressure photoionization mass spectrometry using flow injection analysis for the study of Alzheimer's disease","volume":"131","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","journal-title":"Talanta"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-150336","article-title":"Targeted Lipidomics of Fontal Cortex and Plasma Diacylglycerols (DAG) in Mild Cognitive Impairment and Alzheimer's Disease: Validation of DAG Accumulation Early in the Pathophysiology of Alzheimer's Disease","volume":"48","author":"PL Wood","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e17299","DOI":"10.1371\/journal.pone.0017299","article-title":"Lipid pathway alterations in Parkinson's disease primary visual cortex","volume":"6","author":"D Cheng","year":"2011","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/postgradmedj-2015-133247","article-title":"Cognitive impairment in Parkinson's disease","volume":"91","author":"J Cosgrove","year":"2015","journal-title":"Postgrad Med J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5607\/en.2014.23.4.352","article-title":"What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?","volume":"23","author":"D Kim","year":"2014","journal-title":"Exp Neurobiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis","volume":"16","author":"DJ Irwin","year":"2017","journal-title":"Lancet Neurol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1749-6632.1991.tb00217.x","article-title":"Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease","volume":"640","author":"EK Perry","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/NEN.0b013e31827c5710","article-title":"Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies","volume":"72","author":"EB Mukaetova-Ladinska","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-015-1392-5","article-title":"Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease","volume":"129","author":"AK Liu","year":"2015","journal-title":"Acta Neuropathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/jnnp-2011-300828","article-title":"Grey matter atrophy in cognitively impaired Parkinson's disease","volume":"83","author":"TR Melzer","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e0127396","DOI":"10.1371\/journal.pone.0127396","article-title":"Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia Stages","volume":"10","author":"F Blanc","year":"2015","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","article-title":"Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes","volume":"129","author":"L Walker","year":"2015","journal-title":"Acta Neuropathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/WNL.0b013e3182735e9a","article-title":"GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology","volume":"79","author":"D Tsuang","year":"2012","journal-title":"Neurology"},{"key":"ref23","article-title":"Genetic analysis of \u03b1-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's compared to dementia with Lewy bodies","author":"L Tagliafierro","year":"2017","journal-title":"Alzheimers Dement"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1212\/WNL.0b013e3182a43e45","article-title":"Neuropathologic basis of white matter hyperintensity accumulation with advanced age","volume":"81","author":"D Erten-Lyons","year":"2013","journal-title":"Neurology"},{"key":"ref25","first-page":"88","article-title":"Laboratory methods in histotechnology","author":"AE Downing","year":"1992"},{"key":"ref26","first-page":"13","article-title":"Springer Protocols, Neuromethods","volume":"125","author":"PL Wood","year":"2017"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/ggi.12466","article-title":"Prodromal dementia with Lewy bodies","volume":"15","author":"H Fujishiro","year":"2015","journal-title":"Geriatr Gerontol Int"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/alzrt274","article-title":"The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis","volume":"6","author":"PC Donaghy","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"ref29","first-page":"9","article-title":"Nuclear expression of diacylglycerol kinases: possible involvement in DNA replication","volume":"50","author":"C Evangelisti","year":"2006","journal-title":"Eur J Histochem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.cellsig.2016.07.012","article-title":"Nuclear translocation of PKC\u03b1 isoenzyme is involved in neurogenic commitment of human neural crest-derived periodontal ligament stem cells","volume":"28","author":"O Trubiani","year":"2016","journal-title":"Cell Signal"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbamcr.2014.11.011","article-title":"Downregulation of diacylglycerol kinase \u03b6 enhances activation of cytokine-induced NF-\u03baB signaling pathway","volume":"1853","author":"R Tsuchiya","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.bbrc.2014.03.038","article-title":"Involvement of diacylglycerol produced by phospholipase D activation in A\u03b2-induced reduction of sAPP\u03b1 secretion in SH-SY5Y neuroblastoma cells","volume":"446","author":"F Tanabe","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e77983","DOI":"10.1371\/journal.pone.0077983","article-title":"MicroRNA-34a enhances T cell activation by targeting diacylglycerol kinase \u03b6","volume":"8","author":"J Shin","year":"2013","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fncel.2013.00178","article-title":"Neuronal dark matter: the emerging role of microRNAs in neurodegeneration","volume":"7","author":"EF Goodall","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1194\/jlr.C600019-JLR200","article-title":"Identification and characterization of human ethanolaminephosphotransferase1","volume":"48","author":"Y Horibata","year":"2007","journal-title":"J Lipid Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0005-2760(79)90083-3","article-title":"Choline and ethanolamine glycerophospholipid synthesis in isolated synaptosomes of rat brain","volume":"574","author":"J Strosznajder","year":"1979","journal-title":"Biochim Biophys Acta"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tibs.2006.11.004","article-title":"Diacylglycerol, when simplicity becomes complex","volume":"32","author":"S Carrasco","year":"2007","journal-title":"Trends Biochem Sci"},{"key":"ref38","article-title":"The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction","author":"Y Zilberter","year":"2017","journal-title":"J Neurosci Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1111\/j.1742-4658.2008.06709.x","article-title":"Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease","volume":"275","author":"J Bras","year":"2008","journal-title":"FEBS J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.25729","article-title":"Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson\u2019s disease","volume":"29","author":"SK Abbott","year":"2014","journal-title":"Mov Disord"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1021\/acs.analchem.5b04227","article-title":"Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson Disease","volume":"88","author":"M Boutin","year":"2016","journal-title":"Anal Chem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1748-1716.2011.02298.x","article-title":"Mammalian phospholipase D physiological and pathological roles","volume":"204","author":"X Peng","year":"2012","journal-title":"Acta Physiol (Oxf)"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1471-4159.2005.03315.x","article-title":"Functions and pathophysiological roles of phospholipase D in the brain","volume":"94","author":"J Klein","year":"2005","journal-title":"J Neurochem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tips.2015.01.001","article-title":"The phospholipase D superfamily as therapeutic targets","volume":"36","author":"MA Frohman","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"ref45","first-page":"3","article-title":"Neuroinflammation. Mechanisms and Management","author":"P.L. Wood","year":"2003"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbi.2015.10.012","article-title":"Microglia in dementia with Lewy bodies","volume":"55","author":"WJ Streit","year":"2016","journal-title":"Brain Behav Immun"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40478-015-0209-z","article-title":"Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging","volume":"3","author":"AD Bachstetter","year":"2015","journal-title":"Acta Neuropathol Commun"},{"issue":"Suppl 1","key":"ref48","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1016\/S1353-8020(11)70064-5","article-title":"Neurodegeneration and inflammation in Parkinson's disease","volume":"18","author":"S Phani","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/nen.0b013e31812503e1","article-title":"Common inflammatory mechanisms in Lewy body disease and Alzheimer disease","volume":"66","author":"RE Mrak","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.toxlet.2016.11.002","article-title":"Pathological \u03b1-synuclein exacerbates the progression of Parkinson's disease through microglial activation","volume":"265","author":"QS Zhang","year":"2017","journal-title":"Toxicol Lett"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains","volume":"106","author":"K Imamura","year":"2003","journal-title":"Acta Neuropathol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fnagi.2010.00142","article-title":"Staging anti-inflammatory therapy in Alzheimer's disease","volume":"2","author":"MP Lichtenstein","year":"2010","journal-title":"Front Aging Neurosci"},{"key":"ref53","article-title":"Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?","volume":"2","author":"BP Imbimbo","year":"2010","journal-title":"Front Aging Neurosci"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jmg.2004.024455","article-title":"Parkinsonism among Gaucher disease carriers","volume":"41","author":"O Goker-Alpan","year":"2004","journal-title":"J Med Genet"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","article-title":"Glucocerebrosidase mutations in subjects with parkinsonism","volume":"81","author":"A Lwin","year":"2004","journal-title":"Mol Genet Metab"},{"key":"ref56","first-page":"379","article-title":"Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders","volume":"65","author":"IF Mata","year":"2008","journal-title":"Arch Neurol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"E Sidransky","year":"2009","journal-title":"N Engl J Med"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neuron.2017.01.018","article-title":"The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease","volume":"93","author":"E Aflaki","year":"2017","journal-title":"Neuron"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.bbrc.2016.08.082","article-title":"LRRK2 deficiency impacts ceramide metabolism in brain","volume":"478","author":"R Ferrazza","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.25729","article-title":"Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson\u2019s disease","volume":"29","author":"SK Abbott","year":"2014","journal-title":"Mov Disord"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1021\/acs.analchem.5b04227","article-title":"Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson Disease","volume":"88","author":"M Boutin","year":"2016","journal-title":"Anal Chem"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.bbamcr.2006.08.038","article-title":"The ether lipid-deficient mouse: tracking down plasmalogen functions","volume":"1763","author":"K Gorgas","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1017\/neu.2015.18","article-title":"Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects","volume":"27","author":"PL Wood","year":"2015","journal-title":"Acta Neuropsychiatr"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0191815","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T10:52:59Z","timestamp":1540032779000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0191815"}},"subtitle":[],"editor":[{"given":"Hemant K.","family":"Paudel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":63,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0191815","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,7]]}}}